NO864254L - Neovaskulariseringsinhibitorer og fremgangsmaater til deres fremstilling og bruk. - Google Patents

Neovaskulariseringsinhibitorer og fremgangsmaater til deres fremstilling og bruk.

Info

Publication number
NO864254L
NO864254L NO864254A NO864254A NO864254L NO 864254 L NO864254 L NO 864254L NO 864254 A NO864254 A NO 864254A NO 864254 A NO864254 A NO 864254A NO 864254 L NO864254 L NO 864254L
Authority
NO
Norway
Prior art keywords
procedures
preparation
neovascularization inhibitors
cells
polypeptides
Prior art date
Application number
NO864254A
Other languages
English (en)
Inventor
Bert M Glaser
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of NO864254L publication Critical patent/NO864254L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/849—Eyes; vessels; umbilical cord

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO864254A 1985-02-26 1986-10-23 Neovaskulariseringsinhibitorer og fremgangsmaater til deres fremstilling og bruk. NO864254L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70625985A 1985-02-26 1985-02-26
PCT/US1986/000312 WO1986004783A1 (en) 1985-02-26 1986-02-14 Neovascularization inhibitors and methods for their production and use

Publications (1)

Publication Number Publication Date
NO864254L true NO864254L (no) 1986-10-23

Family

ID=24836851

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864254A NO864254L (no) 1985-02-26 1986-10-23 Neovaskulariseringsinhibitorer og fremgangsmaater til deres fremstilling og bruk.

Country Status (12)

Country Link
US (1) US4996159A (no)
EP (1) EP0213180B1 (no)
JP (1) JPS61246132A (no)
AT (1) ATE81254T1 (no)
AU (1) AU590872B2 (no)
DE (1) DE3686927T2 (no)
DK (1) DK509286A (no)
FI (1) FI864293A7 (no)
NO (1) NO864254L (no)
NZ (1) NZ215195A (no)
WO (1) WO1986004783A1 (no)
ZA (1) ZA861403B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1329123C (en) * 1987-10-13 1994-05-03 Moses Judah Folkman Inhibitor of angiogenesis
JPH04178328A (ja) * 1990-11-08 1992-06-25 Unitika Ltd 血管新生阻害剤
US5853746A (en) * 1991-01-31 1998-12-29 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
ATE208169T1 (de) * 1992-04-01 2001-11-15 Baxter Int Systeme zum einpflanzen von gefässbildendem gewebe
US6319687B1 (en) * 1992-09-24 2001-11-20 The United States Of America As Represented By The Department Of Health And Human Services Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene
US6451763B1 (en) * 1992-06-04 2002-09-17 The United States Of America As Represented By The Department Of Health And Human Services Retinal pigmented epithelium derived neurotrophic factor and methods of use
US5840686A (en) * 1992-09-24 1998-11-24 The United States Of America As Represented By The Department Of Health And Human Services Pigment epithelium-derived factor: characterization of its novel biological activity and sequences encoding and expressing the protein and methods of use
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
US5985330A (en) * 1996-08-05 1999-11-16 Coastside Bio Resources Inhibition of angiogenesis by sea cucumber fractions
DE69739663D1 (de) 1996-12-31 2009-12-31 Antioxidant Pharmaceuticals Co Pharmazeutische glutathionpräparate und methoden zu dern verabreichung
US6797691B1 (en) * 1997-07-23 2004-09-28 Northwestern University Methods and compositions for inhibiting angiogenesis
CA2298018C (en) 1997-07-23 2008-12-16 Northwestern University Methods and compositions for inhibiting angiogenesis
US7105496B2 (en) * 1998-07-23 2006-09-12 Northwestern University Methods and compositions for inhibiting angiogenesis
US7828827B2 (en) * 2002-05-24 2010-11-09 Corium International, Inc. Method of exfoliation of skin using closely-packed microstructures
US6875165B2 (en) * 2001-02-22 2005-04-05 Retinalabs, Inc. Method of radiation delivery to the eye
US7070554B2 (en) 2003-01-15 2006-07-04 Theragenics Corporation Brachytherapy devices and methods of using them
US7563222B2 (en) 2004-02-12 2009-07-21 Neovista, Inc. Methods and apparatus for intraocular brachytherapy
AU2005214040B2 (en) * 2004-02-12 2011-03-31 Neo Vista, Inc. Methods and apparatus for intraocular brachytherapy
BRPI0618677A2 (pt) * 2005-11-15 2011-09-06 Neovista Inc métodos e aparelho para braquiterapia intra-ocular
AU2008209537B2 (en) * 2007-01-22 2013-01-31 Corium Pharma Solutions, Inc. Applicators for microneedle arrays
US8911749B2 (en) * 2007-04-16 2014-12-16 Corium International, Inc. Vaccine delivery via microneedle arrays
AU2008241470B2 (en) * 2007-04-16 2013-11-07 Corium Pharma Solutions, Inc. Solvent-cast microneedle arrays containing active
BRPI0913380A2 (pt) 2008-06-04 2015-11-24 Neovista Inc sistema portátil de liberação de radiação para o avanço de um fio de fonte de radiação
ES2634667T3 (es) * 2009-04-24 2017-09-28 Corium International, Inc. Métodos para fabricar conjuntos de microproyección
WO2011140274A2 (en) 2010-05-04 2011-11-10 Corium International, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
JP6865524B2 (ja) 2012-12-21 2021-04-28 コリウム， インコーポレイテッド 治療剤を送達するためのマイクロアレイおよび使用方法
CA3130120A1 (en) 2013-03-12 2014-10-09 Corium, Inc. Microprojection applicators
US10384045B2 (en) 2013-03-15 2019-08-20 Corium, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
RU2711567C2 (ru) 2013-03-15 2020-01-17 Кориум, ИНК. Микрочип для доставки лекарственного средства и способы его использования
JP6689187B2 (ja) 2013-03-15 2020-04-28 コリウム， インコーポレイテッド 複数の衝突微小突起アプリケータおよび使用方法
WO2014144973A1 (en) 2013-03-15 2014-09-18 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
EP3188714A1 (en) 2014-09-04 2017-07-12 Corium International, Inc. Microstructure array, methods of making, and methods of use
US20160367620A1 (en) 2015-06-19 2016-12-22 Harry B. Demopoulos Glutathione
WO2017004067A1 (en) 2015-06-29 2017-01-05 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US30239A (en) * 1860-10-02 Improvement in machines for stem m ing corn-husks
US4042457A (en) * 1975-11-10 1977-08-16 Rush-Presbyterian-St. Luke's Medical Center Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor
USRE30239E (en) * 1975-11-10 1980-03-25 Cell proliferation and tissue invasion inhibitor
US4182753A (en) * 1978-03-29 1980-01-08 Saltarelli Cora G Sarcoma 180 tumor inhibitor and method of making same
US4176177A (en) * 1978-11-16 1979-11-27 Rush-Presbyterian-St. Luke's Medical Center Inhibition of bone resorption
US4356261A (en) * 1980-04-22 1982-10-26 Rush-Presbyterian-St. Luke's Medical Center Anti-invasion factor containing cultures
US4534967A (en) * 1982-08-03 1985-08-13 Boston Biomedical Research Institute Cell proliferation inhibitor and method of preparation

Also Published As

Publication number Publication date
ZA861403B (en) 1986-12-30
WO1986004783A1 (en) 1986-08-28
FI864293L (fi) 1986-10-23
ATE81254T1 (de) 1992-10-15
FI864293A0 (fi) 1986-10-23
DK509286D0 (da) 1986-10-24
NZ215195A (en) 1991-11-26
DE3686927T2 (de) 1993-03-25
DE3686927D1 (de) 1992-11-12
EP0213180B1 (en) 1992-10-07
FI864293A7 (fi) 1986-10-23
AU5455386A (en) 1986-09-10
US4996159A (en) 1991-02-26
EP0213180A4 (en) 1988-12-28
AU590872B2 (en) 1989-11-23
JPS61246132A (ja) 1986-11-01
DK509286A (da) 1986-10-24
EP0213180A1 (en) 1987-03-11

Similar Documents

Publication Publication Date Title
NO864254L (no) Neovaskulariseringsinhibitorer og fremgangsmaater til deres fremstilling og bruk.
JP2550307B2 (ja) 腫瘍増殖阻害因子およびその調製方法
NO820090L (no) Fremgangsmaate for fremstilling og behandling av renninderivater
DE3268915D1 (en) Angiotropins of leukocytes and inflamed tissue: a new class of natural chemotropic protein mitogens for specific induction of directional growth of blood vessels, neovascularization of tissues and morphogenesis of blood vessel patterns, process for their biotechnical preparation and pharmaceutical compositions
DK0696205T3 (da) Anvendelse af neuro-afledte fetale cellelinier til transplantationsterapi
NZ223506A (en) Tissue factor protein, dna encoding it, vectors, host cells, production of the protein and pharmaceutical compositions
DE69433371D1 (de) Polypeptid, fähig zur Inhibierung der Bindung zwischen menschliches IL-6 und dessen Rezeptor
EP0751992A4 (en) VASCULAR ENDOTHELIAL GROWTH FACTOR 2
NO890587D0 (no) Nye proteiner med faktor viii aktivitet: fremgangsmaate for fremstilling derav ved anvendelse av genetisk omkonstruerte celler og farmasoeytiske sammensetninger som inneholder disse.
DK85786A (da) Biologisk aktive fragmenter af human antihaemofilisk faktor og fremgangsmaade til fremstilling deraf
DE69635924D1 (de) Isolierung und züchtung von schwannzellen
AU2742892A (en) An anticoagulant substance obtained from urine
FI885031A0 (fi) Vaextregulator av blodplaettetyp.
WO2024238955A3 (en) Relaxin-2 fusion protein analogs and methods of using same
DK393188D0 (da) Farmaceutisk praeparat til intranasal administrering
NO931413D0 (no) Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer
DK433686D0 (da) Dna-sekvenser, rekombinant-dna-molekyler og fremgangsmaader til fremstilling af humane lipocortin-lignende polypeptider
ES2162331T3 (es) Utilizacion del factor de crecimiento del tejido nervioso para conservacion, cultivo o tratamiento de la cornea.
NO941444L (no) Fremgangsmåte og materiale for bestemmelse av bioaktive substansers immunologiske aktivitet
IL99940A0 (en) Beta-galactoside binding proteins,methods for the production thereof,and pharmaceutical compositions containing the same
DK93390A (da) Ufuldstaendige hepadnavira og cellelinie, der producerer vacciner, samt behandling af leversygdomme og -forstyrrelser
NO893256D0 (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
DE3772193D1 (de) Verwendung von pteridinen und/oder purinen oder eines xanthinoxidase-hemmers zur herstellung eines arzneimittels zur behandlung von genetisch bedingten degenerativen netzhauterkrankungen.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DK0504291T3 (da) Nye proteiner med oncostatin M-aktivitet og fremgangsmåde til deres fremstilling